Product NDC: | 55154-1056 |
Proprietary Name: | MAXIPIME |
Non Proprietary Name: | CEFEPIME HYDROCHLORIDE |
Active Ingredient(s): | 1 g/1 & nbsp; CEFEPIME HYDROCHLORIDE |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55154-1056 |
Labeler Name: | Cardinal Health |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA050679 |
Marketing Category: | NDA |
Start Marketing Date: | 19960118 |
Package NDC: | 55154-1056-5 |
Package Description: | 5 VIAL in 1 BAG (55154-1056-5) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
NDC Code | 55154-1056-5 |
Proprietary Name | MAXIPIME |
Package Description | 5 VIAL in 1 BAG (55154-1056-5) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
Product NDC | 55154-1056 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | CEFEPIME HYDROCHLORIDE |
Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 19960118 |
Marketing Category Name | NDA |
Labeler Name | Cardinal Health |
Substance Name | CEFEPIME HYDROCHLORIDE |
Strength Number | 1 |
Strength Unit | g/1 |
Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |